How Do Analysts Feel About Impact BioMedical Inc (IBO)?

Impact BioMedical Inc (IBO) saw downtrend of -27.42% in the recent trading with $3.60 being its most recent. The current price level -41.65% lower than the highest price of $6.17 marked by the stock while trading over the past 52-weeks, whereas it is 608.66% higher than the lowest price of $0.51 the company dropped to over past 52-weeks. The latest news story on IBO appeared in (GlobeNewswire) under the title “Impact Biomedical Inc. Announcement Stock Activity/Pricing” on.

Looking into the simple moving average, Impact BioMedical Inc (IBO)’s stock stands at a SMA-50 of $24.84 while that of 5-day is reading $24.84.

Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and IBO’s SMA-200 as of now is $24.11.

Impact BioMedical Inc Earnings – What Happened With IBO

Coming around sales and income figures on IBO Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.

IBO – Impact BioMedical Inc Stock Earnings Estimates

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 11.50 million. IBO does have institutional investors; and they hold 0.77% of the stock.

Impact BioMedical Inc – Insider Activity and Holdings

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Impact BioMedical Inc has a debt to equity ratio of 0.26.

Technical Analysis of Impact BioMedical Inc (AMEX:IBO) stock